E-prescribing also known as electronic prescribing is a technology framework that permits medical physicians and practitioners to transfer or send prescriptions to a participating pharmacy electronically instead of using handwritten or faxed notes or calling in prescriptions. The E-Prescribing system is used in various applications including patient historical data, data security checks, preparation of complete medication list, and complete information of formulary. The global E-prescribing market is expected to witness considerable growth owing to growing government programs to implement E-prescribing system to improve the quality of healthcare and reduce medication errors.
E-Prescribing is gaining importance in medical record systems and Rising demand for cloud-based solutions
Government Initiatives and Incentive Programs have led to the demand of E-prescribing system, More focus on minimizing the medication errors and Advanced features of E-prescribing system drive the market growth
Emerging economies in Asia Pacific region such as India, China and Japan
The Players Covered in the Study are:
Cerner Corporation (U.S), Athenahealth, Inc. (U.S), Allscripts (U.S), eClinicalWorks (U.S), DrFirst (U.S), Practice Fusion, Inc. (U.S), Emdeon (U.S), Surescripts (U.S), Henry Schein, Inc. (U.S) and HealthFusion, Inc. (U.S)
On March 31, 2010, DEA's Interim Final Rule with Request for Comment titled "Electronic Prescriptions for Controlled Substances" was published in the Federal Register. The rule became effective June 1, 2010. and The rule revises DEA regulations to provide practitioners with the option of writing prescriptions for controlled substances electronically. The regulations also permit pharmacies to receive, dispense, and archive these electronic prescriptions. These regulations are an addition to, not a replacement